Tag: rare diseases
8th Annual Warner Advocacy Award: Call for Nominations
Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize …
READ MOREPatient Education on Carcinoid Syndrome: From Diagnosis to Treatment
A Live Online Event on Wednesday, March 1, 11 am to 12 noon Eastern Standard Time
Ask Your Questions during the Live Program or Submit Them in Advance
Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient…
READ MORENeuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium
Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…
READ MORELexicon’s Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial
Lexicon Pharmaceuticals Inc. has announced that the pivotal phase III clinical trial, TELESTAR, of its oral drug candidate telotristat etiprate met the primary endpoint in treating cancer patients with carcinoid syndrome that is not adequately controlled…
READ MORECall for Nominations: 6th Annual Warner Advocacy Award
Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? Novartis Oncology and The NET Alliance are searching for an outstanding NET patient advocate to recognize and honor with the 6th Annual Warner Advocacy …
READ MORE15 Videos from the 3rd Theranostics World Congress
The 3rd Theranostics World Congress featured a patient education day on Saturday, March 14, made possible with support from the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation. The NorCal CarciNET Community provided funding to…
READ MOREMarch 30 Is National Doctors’ Day
March 30 is NATIONAL DOCTORS’ DAY. In recognition of carcinoid/neuroendocrine tumor (NET) doctors – you are our heroes and superheroes!! Pictured are some of the NET specialists throughout the United States.
Pictured by columns, left to right, top …
READ MOREBreaking News: US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors
December 16, 2014: The US Food and Drug Administration (FDA) today approved “lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic…
READ MORE1st Annual Tommyland Invitational Charity Golf Tournament to Benefit Carcinoid Cancer Foundation
The 1st Annual Tommyland Tourney, a charity golf tournament to benefit the Carcinoid Cancer Foundation, will be held at Schneiter’s Riverside Golf Course in Riverdale, Utah on Sunday, September 14th. The tournament is being held in memory of …
READ MOREClinical Trial for GI Carcinoid Patients Recruiting Through September
Gastrointestinal carcinoid patients who have tumors that either are not suitable for standard treatment or are not responding to standard treatment have the opportunity to enroll in a Phase I/II clinical trial conducted by Tekmira Pharmaceuticals…
READ MORE